The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials - PubMed

Affiliations

• PMID: 23512497
• DOI: 10.1055/s-0032-1328321

Free article

Review

The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials

Hui Dong et al. Planta Med. 2013 Apr.

Free article

Abstract

Clinical trials have reported lipid-lowering effects of berberine intake, but the findings have been inconsistent. The aim of this meta-analysis was to assess the safety of berberine and its effects on blood lipid profiles. A systemic review was designed, undertaken and reported in accordance with the PRISMA statement. Randomized controlled trials of the effects of berberine on blood lipids in adults were included. Study population characteristics and the main results, including changes in the levels of total cholesterol, triglycerides, low-density and high-density lipoprotein cholesterol, were extracted. Weighted mean differences were calculated for net changes in blood lipid concentrations using fixed-effect or random-effects models. After filtering, eleven randomized controlled trials (including a total of 874 participants) were included in this study. The methodological quality of these studies was generally low. The final analysis showed that administration of berberine produced a significant reduction in total cholesterol (mean difference - 0.61 mmol/L; 95 % confidence interval - 0.83 to - 0.39), triglycerides (mean difference - 0.50 mmol/L; 95 % confidence interval - 0.69 to - 0.31), and low-density lipoprotein cholesterol (mean difference - 0.65 mmol/L; 95 % confidence interval - 0.76 to - 0.54) levels, with a remarkable increase in high-density lipoprotein (mean difference 0.05 mmol/L; 95 % confidence interval 0.02 to 0.09). No serious adverse effects of berberine have been reported. In conclusion, berberine may have beneficial effects in the control of blood lipid levels. However, the efficacy of berberine in treating hyperlipidemia should be further evaluated by more randomized controlled trials in a larger population of patients.

Similar articles

• Efficacy and Safety of Berberine Alone or Combined with Statins for the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.

  Zhang LS, Zhang JH, Feng R, Jin XY, Yang FW, Ji ZC, Zhao MY, Zhang MY, Zhang BL, Li XM. Zhang LS, et al. Am J Chin Med. 2019;47(4):751-767. doi: 10.1142/S0192415X19500393. Epub 2019 May 16. Am J Chin Med. 2019. PMID: 31094214

• Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials.

  Ju J, Li J, Lin Q, Xu H. Ju J, et al. Phytomedicine. 2018 Nov 15;50:25-34. doi: 10.1016/j.phymed.2018.09.212. Epub 2018 Sep 28. Phytomedicine. 2018. PMID: 30466986

• The effect of a dual combination of noninsulin antidiabetic drugs on lipids: a systematic review and network meta-analysis.

  Dai X, Wang H, Jing Z, Fu P. Dai X, et al. Curr Med Res Opin. 2014 Sep;30(9):1777-86. doi: 10.1185/03007995.2014.921608. Epub 2014 May 28. Curr Med Res Opin. 2014. PMID: 24805140 Review.

• Lipid-lowering efficacy of rosuvastatin.

  Adams SP, Sekhon SS, Wright JM. Adams SP, et al. Cochrane Database Syst Rev. 2014 Nov 21;2014(11):CD010254. doi: 10.1002/14651858.CD010254.pub2. Cochrane Database Syst Rev. 2014. PMID: 25415541 Free PMC article. Review.

Cited by

• Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats.

  Gong J, Hu M, Huang Z, Fang K, Wang D, Chen Q, Li J, Yang D, Zou X, Xu L, Wang K, Dong H, Lu F. Gong J, et al. Front Pharmacol. 2017 Feb 3;8:42. doi: 10.3389/fphar.2017.00042. eCollection 2017. Front Pharmacol. 2017. PMID: 28217099 Free PMC article.

• Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora.

  Liu X, Wang L, Tan S, Chen Z, Wu B, Wu X. Liu X, et al. Front Pharmacol. 2022 Mar 2;13:814871. doi: 10.3389/fphar.2022.814871. eCollection 2022. Front Pharmacol. 2022. PMID: 35308208 Free PMC article. Review.

• Phytochemical Compounds and Protection from Cardiovascular Diseases: A State of the Art.

  Pagliaro B, Santolamazza C, Simonelli F, Rubattu S. Pagliaro B, et al. Biomed Res Int. 2015;2015:918069. doi: 10.1155/2015/918069. Epub 2015 Oct 4. Biomed Res Int. 2015. PMID: 26504846 Free PMC article. Review.

• Nutraceuticals in Paediatric Patients with Dyslipidaemia.

  Banderali G, Capra ME, Viggiano C, Biasucci G, Pederiva C. Banderali G, et al. Nutrients. 2022 Jan 27;14(3):569. doi: 10.3390/nu14030569. Nutrients. 2022. PMID: 35276928 Free PMC article. Review.

• Naturally Occurring PCSK9 Inhibitors.

  Adorni MP, Zimetti F, Lupo MG, Ruscica M, Ferri N. Adorni MP, et al. Nutrients. 2020 May 16;12(5):1440. doi: 10.3390/nu12051440. Nutrients. 2020. PMID: 32429343 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Georg Thieme Verlag Stuttgart, New York

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations